In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott gets an option to acquire Advanced Cardiac Therapeutics

Executive Summary

Paired with announcements regarding the acquisition of Topera Medical Inc. and a minority investment in VytronUS, Abbott Laboratories Inc. continues on its quest to make a strong entry into the electrophysiology market through also gaining the option to acquire Advanced Cardiac Therapeutics Inc. (ACT), a privately owned firm developing a new cardiac ablation catheter.

Deal Industry
  • Medical Devices
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies